Will Trump announce Kyle Diamantas as the next FDA commissioner by December 31?
BUY YES
- Cost
- 12.0¢
- Implied chance
- 12.0%
- Return if right
- 733.3%
- Spread cost
- 5%
If you put in $100
You get 833.3 shares at 12.0¢ each.
YES wins: $833.33 back, a profit of $733.33. YES loses: $0.00, and the whole $100 is gone.
The gap between buyers and sellers takes $36.23 of that profit. Without it you would make $769.57.
Assumes the whole order fills at this price. A large order eats into the book and averages worse.
Buy YES on Polymarket
BUY NO
- Cost
- 89.0¢
- Implied chance
- 89.0%
- Return if right
- 12.4%
- Spread cost
- 5%
If you put in $100
You get 112.4 shares at 89.0¢ each.
NO wins: $112.36 back, a profit of $12.36. NO loses: $0.00, and the whole $100 is gone.
The gap between buyers and sellers takes $0.63 of that profit. Without it you would make $12.99.
Assumes the whole order fills at this price. A large order eats into the book and averages worse.
Buy NO on Polymarket
- Kyle Diamantas11.5%
- No announcement by December 3130.6%
- Brett Giroir9.3%
- Sara Brenner6.0%
- Stephen Hahn5.9%
- Grace Graham3.7%
Latest: Aug 10, 03:42 PM
Latest news
headlines link to their publishersNo recent headlines matched this market. We only show an article when the names in the question appear in its headline, so a very local or very new market often has nothing. Showing nothing is deliberate: an unrelated story here would read like evidence about the price.
Headlines are matched on the names in “Will Trump announce Kyle Diamantas as the next FDA commissio…”. Nobody checks them by hand, so one may not be relevant. They also say nothing about whether the price has already moved on this news.
How this market resolves
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner. An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs. Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner. Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify. Media reports, speculation, or other unofficial information will not qualify. A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market. Formal nominations are defined as the submission of a nomination message to the U.S. Senate. If Donald Trump does not announce his pick for the next United States Food and Drug Administration (FDA) Commissioner by December 31, 2026, 11:59 PM ET, this market will resolve to “No announcement by December 31”. The resolution source for this market will be official information from Donald Trump and the Trump Administration; however, a consensus of credible reporting may also be used.
Other outcomes in Who will Trump announce as next FDA commissioner?
- Will Trump announce Grace Graham as the next FDA commissioner by December 31?
- Will Trump announce Sara Brenner as the next FDA commissioner by December 31?
- Will Trump announce Stephen Hahn as the next FDA commissioner by December 31?
- Will Trump announce Brett Giroir as the next FDA commissioner by December 31?
- Will Trump make no announcement for the next FDA commissioner by December 31?